Facebook faced serious allegations this week. An investigation revealed the company sold user data indicating depression to drug makers. This information helped pharmaceutical firms target ads for medications. The practice occurred over several years. Facebook tracked user posts and activities. It identified people showing signs of mental health struggles. Then it packaged this sensitive data for sale. Buyers included major antidepressant manufacturers. These companies sought users likely needing their products.
(Facebook Was Exposed To Sell Depression User Data To Pharmaceutical Companies For Advertising Targeting)
Internal documents confirmed the data deals. Emails showed Facebook employees discussing the targeting strategy. They specifically referenced users with depression symptoms. Privacy experts condemned the actions immediately. They called it a severe betrayal of trust. Health information requires strong protection. Using it for profit violates ethical standards. Facebook prioritized advertising revenue over user wellbeing.
Legal authorities in multiple countries launched probes. Selling health data without clear consent may break laws. Facebook could face heavy fines. Past promises about data protection now seem hollow. The company previously vowed to safeguard mental health information. This incident proves otherwise.
(Facebook Was Exposed To Sell Depression User Data To Pharmaceutical Companies For Advertising Targeting)
Teen users were particularly affected. Facebook included younger demographics in the data sales. Parents expressed anger upon learning this. Many felt the company exploited vulnerable youth. Advocacy groups demanded immediate policy changes. They urged lawmakers to ban health-based ad targeting permanently. Facebook offered no official statement. Its silence deepened public frustration.
